Showing results (321-330 of 552) with videos related to
Sort By:
Pageof 56
European Journal of Pharmacology|November 15, 1994
Selegiline enhances survival and neurite outgrowth of MPP(+)-treated dopaminergic neuronsE Koutsilieri, J F O'Callaghan, T S Chen, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|April 10, 2007
Functional polymorphisms of the 5-HT1A and 5-HT1B receptor are associated with clinical symptoms in migraineursM Marziniak, R Mössner, C Kienzler, et al.Progress in Neurobiology|March 24, 2005
Neuromelanin in human dopamine neurons: comparison with peripheral melanins and relevance to Parkinson's diseaseH Fedorow, F Tribl, G Halliday, et al.Dementia and Geriatric Cognitive Disorders|February 15, 2001
Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patientsK Braunewell, P Riederer, C Spilker, et al.Neuroscience Letters|October 24, 1994
Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patientsM Mogi, M Harada, T Kondo, et al.Annals of Neurology|May 1, 1986
Dopamine D2 receptor density remains constant in treated Parkinson's diseaseM Guttman, P Seeman, G P Reynolds, et al.Psychiatry Research|December 1, 1990
Glucocorticoid receptors on mononuclear leukocytes in Alzheimer's diseaseR Rupprecht, L Frölich, T Mergenthaler, et al.Neuroscience Letters|December 20, 1996
The soluble form of Fas molecule is elevated in parkinsonian brain tissuesM Mogi, M Harada, T Kondo, et al.European Journal of Pharmacology|July 6, 1993
Nimodipine inhibits [3H]nitrobenzylthioinosine binding to the adenosine transporter in human brainJ Deckert, B Bereznai, A Hennemann, et al.Neuroscience Letters|September 6, 1996
bcl-2 protein is increased in the brain from parkinsonian patientsM Mogi, M Harada, T Kondo, et al.Pageof 56